LACTOBACILLUS PLANTARUM BNT_G401 STRAIN AND USE THEREOF

Provided are a novel Lactiplantibacillus plantarum BNT_G401 strain and uses thereof. A method for manufacturing a γ-aminobutyric acid (GABA) containing fermented product includes (a) dissolving in water a Curcuma longa L. extract having a solid content of 0.5 to 10%; monosodium glutamate (MSG); a ca...

Full description

Saved in:
Bibliographic Details
Main Authors Seok, Chang Hwan, Gwak, Yun Geum Sang, Shin, Ji Won, Jang, Gi Hyun, Kim, Yu Mi
Format Patent
LanguageEnglish
Published 21.12.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided are a novel Lactiplantibacillus plantarum BNT_G401 strain and uses thereof. A method for manufacturing a γ-aminobutyric acid (GABA) containing fermented product includes (a) dissolving in water a Curcuma longa L. extract having a solid content of 0.5 to 10%; monosodium glutamate (MSG); a carbon source; and a nitrogen source, and sterilizing the same to manufacture a medium composition; (b) inoculating the medium composition with a Lactiplantibacillus plantarum strain; and (c) fermenting the medium composition in which the strain is inoculated to manufacture a GABA containing fermented product.
Bibliography:Application Number: US202318459977